Guangdong Longchuangji Pharmaceutical Co., Ltd. announced a private placement to issue shares for an aggregate gross proceeds CNY 30,000,000 on January 19, 2024. The transaction will include participation from new investor Shanxi Zhendong Pharmaceutical Co.,Ltd for 6.015% in the company. The company held the 14th meeting of the fifth session of the Board of Directors and unanimously reviewed and approved the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.01 CNY | +6.60% | +11.33% | -25.78% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-25.78% | 667M | |
+31.54% | 662B | |
+21.96% | 546B | |
-5.29% | 359B | |
+17.02% | 323B | |
+4.76% | 289B | |
+13.68% | 234B | |
+3.81% | 198B | |
-10.63% | 194B | |
+4.01% | 167B |
- Stock Market
- Equities
- 300158 Stock
- News Shanxi Zhendong Pharmaceutical Co.,Ltd
- Guangdong Longchuangji Pharmaceutical Co., Ltd. announced that it expects to receive CNY 30 million in funding from Shanxi Zhendong Pharmaceutical Co.,Ltd